Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.
about
Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compoundsNitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activityCell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progressionNo effect of NGAL/lipocalin-2 on aggressiveness of cancer in the MMTV-PyMT/FVB/N mouse model for breast cancerProfilin 1 as a target for cathepsin X activity in tumor cellsIdentification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasisFor robust big data analyses: a collection of 150 important pro-metastatic genesPrognostic and predictive value of cathepsin X in serum from colorectal cancer patients.A role for cathepsin Z in neuroinflammation provides mechanistic support for an epigenetic risk factor in multiple sclerosisCathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.Characterization of the MDSC proteome associated with metastatic murine mammary tumors using label-free mass spectrometry and shotgun proteomicsOverexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinomaDistinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix.Induction of premalignant host responses by cathepsin x/z-deficiency in Helicobacter pylori-infected mice.Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions.Development of activity-based probes for cathepsin X.The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot studyMacrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer.Cathepsin X Cleaves Profilin 1 C-Terminal Tyr139 and Influences Clathrin-Mediated Endocytosis.Differential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target.Cathepsin X in serum from patients with colorectal cancer: relation to prognosis.Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancerMelittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinomaCross-talk between Dopachrome Tautomerase and Caveolin-1 Is Melanoma Cell Phenotype-specific and Potentially Involved in Tumor Progression.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Inhibition of cathepsin X enzyme influences the immune response of THP-1 cells and dendritic cells infected with Helicobacter pylori.Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model.Improved quenched fluorescent probe for imaging of cysteine cathepsin activity.Cathepsin B as a potential prognostic and therapeutic marker for human lung squamous cell carcinoma.Proteolytic networks in cancerExtracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters.Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity.Specialized roles for cysteine cathepsins in health and disease.Cancer-associated lysosomal changes: friends or foes?Cysteine cathepsins and their potential in clinical therapy and biomarker discovery.Design of a highly selective quenched activity-based probe and its application in dual color imaging studies of cathepsin S activity localization.Proteomic Identification of Cysteine Cathepsin Substrates Shed from the Surface of Cancer Cells.Lysosomal processing of progranulinInactivation of tristetraprolin in chronic hypoxia provokes the expression of cathepsin B.Nicotine alters the proteome of two human pancreatic duct cell lines.
P2860
Q27667908-B4434ABB-EDB0-4D93-B6B8-6CDD6A72412AQ28260087-F9EE8076-3631-40F7-B3AD-549C2DDDF980Q28299475-10ED3FA6-AB69-4DD8-9A3E-50BD9F6637BBQ28480579-68A628B6-5A3D-4EDF-865B-37C13602D36AQ28484945-C7E79591-3174-4BB7-928B-449521E427F5Q28506334-881F3A0C-AE8C-46F8-BD24-BBA98B0BE145Q31155755-708D5D41-EBF7-4009-94D5-476F338252F4Q33612332-49783E2D-340C-4EA2-8A2C-E9ED36EA998CQ33655029-CE532139-3391-4539-AF5B-09A48300D068Q33721128-75E6D1AA-1F72-4E8E-8D4F-CD6F40443998Q33996767-83F0C483-8C56-44B3-9ADC-DFB6D9309DC9Q34037880-966AEC77-AD52-41F4-BF5D-48461EF83DC0Q34271356-805C6F7B-C26D-43A2-A262-94BC4FCC00E8Q34363406-EDEA94D7-F2FB-4DA4-8B76-591AC600AB42Q34619781-327DB356-A800-42F3-8A5D-E8B8863CB350Q35053426-24F8F87D-E563-4189-8E44-435BB64BEB3BQ35623073-A8CAD06F-C03E-4F4A-BDFB-B69768F11616Q35624725-B6409B74-3CD2-4880-A425-0F311E90C2ECQ35761041-FED4E96A-41FA-4D8A-A07C-D9EDC160D018Q36087869-5BBBFC80-285B-42E6-B530-12F22703E794Q36322404-7AED5160-E206-436D-BAAB-852115843275Q36480910-95C1095D-A80C-42A7-A990-21F4A7E20012Q36502706-B5BC3EDB-951C-4C75-938A-FB57E38EC2E7Q37066559-BE213537-8667-46AC-B292-129C0A9521C9Q37121662-B6F95029-3438-4C87-97DA-D43798AB2664Q37225406-85229E2F-25BD-4A8D-8231-A78605134AE1Q37270829-E88A91BD-8EB3-49BA-977A-B0D9327ED748Q37304778-C46814FC-AFE3-4924-8F11-4232B6149719Q37327749-E21CB77B-6F0B-47AA-AC61-ED9F1885F4C8Q37343319-DCD656CB-8DDD-4668-89AC-32FF76E963DAQ37620999-A778AD34-B6AE-41B5-82D3-8311D3FDA170Q37699783-12D1018C-10FA-4D6E-BDCF-BABC067781E7Q37797839-EA955399-CD61-4E45-BD34-29FE01AD75A9Q38025001-014DC16C-7EAA-4AFD-8479-925C58F34743Q38182521-4C86CFB8-37A0-42FA-99B6-8973C31DFCBAQ38320736-21AD6C9B-3555-4DC1-B15C-5223A36E14C7Q38409707-5949E176-8592-455A-9E6A-3D136B88FAD6Q38611308-42EDAC4B-CB8F-4C57-979D-ACFD01F98C83Q38934467-81F84636-A618-423E-9DC1-D41D3C6BBEA2Q38952671-A326C3A5-1E99-4102-BB2B-40855CF41D8F
P2860
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Synergistic antitumor effects ...... ession and metastasis in mice.
@ast
Synergistic antitumor effects ...... ession and metastasis in mice.
@en
type
label
Synergistic antitumor effects ...... ession and metastasis in mice.
@ast
Synergistic antitumor effects ...... ession and metastasis in mice.
@en
prefLabel
Synergistic antitumor effects ...... ession and metastasis in mice.
@ast
Synergistic antitumor effects ...... ession and metastasis in mice.
@en
P2093
P2860
P50
P356
P1476
Synergistic antitumor effects ...... ression and metastasis in mice
@en
P2093
Anne Schwinde
Christoph Peters
Fee Werner
Kathrin Sachse
Lisa Sevenich
Mieczyslaw Gajda
Nicole Klemm
Olga Vasiljeva
P2860
P304
P356
10.1073/PNAS.0907240107
P407
P577
2010-01-21T00:00:00Z